Pulike Biological Engineering, Inc. (603566.SS)
CNY 13.32
(4.96%)
CNY 13.32
(4.96%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 193.01 Million CNY | 5.35% |
| 2022 | 183.2 Million CNY | -35.62% |
| 2021 | 284.58 Million CNY | 15.41% |
| 2020 | 246.58 Million CNY | 130.71% |
| 2019 | 106.88 Million CNY | -21.83% |
| 2018 | 136.73 Million CNY | 26.74% |
| 2017 | 107.89 Million CNY | -41.06% |
| 2016 | 183.05 Million CNY | 18.63% |
| 2015 | 154.3 Million CNY | -2.1% |
| 2014 | 157.6 Million CNY | -6.76% |
| 2013 | 169.04 Million CNY | 19.14% |
| 2012 | 141.88 Million CNY | 7.19% |
| 2011 | 132.36 Million CNY | 42.4% |
| 2010 | 92.95 Million CNY | -14.79% |
| 2009 | 109.08 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 31.44 Million CNY | -21.02% |
| 2024 Q1 | 29.98 Million CNY | 655.38% |
| 2024 Q2 | 44.57 Million CNY | 48.66% |
| 2023 Q2 | 55.23 Million CNY | -27.99% |
| 2023 Q4 | -5.39 Million CNY | -108.12% |
| 2023 FY | 193.01 Million CNY | 5.35% |
| 2023 Q3 | 66.46 Million CNY | 20.33% |
| 2023 Q1 | 76.71 Million CNY | 105.11% |
| 2022 Q3 | 53.99 Million CNY | 7.48% |
| 2022 FY | 183.2 Million CNY | -35.62% |
| 2022 Q4 | 37.39 Million CNY | -30.74% |
| 2022 Q1 | 41.57 Million CNY | 0.45% |
| 2022 Q2 | 50.24 Million CNY | 20.85% |
| 2021 Q4 | 41.38 Million CNY | -36.04% |
| 2021 FY | 284.58 Million CNY | 15.41% |
| 2021 Q1 | 101.81 Million CNY | 63.97% |
| 2021 Q3 | 64.69 Million CNY | -15.63% |
| 2021 Q2 | 76.68 Million CNY | -24.68% |
| 2020 Q2 | 75.34 Million CNY | 20.19% |
| 2020 Q1 | 62.68 Million CNY | 629.82% |
| 2020 FY | 246.58 Million CNY | 130.71% |
| 2020 Q3 | 46.46 Million CNY | -38.32% |
| 2020 Q4 | 62.09 Million CNY | 33.63% |
| 2019 Q1 | 10.85 Million CNY | 64.27% |
| 2019 FY | 106.88 Million CNY | -21.83% |
| 2019 Q3 | 33.13 Million CNY | -38.98% |
| 2019 Q4 | 8.58 Million CNY | -74.08% |
| 2019 Q2 | 54.3 Million CNY | 400.49% |
| 2018 Q1 | 42.62 Million CNY | 84.48% |
| 2018 FY | 136.73 Million CNY | 26.74% |
| 2018 Q3 | 42.43 Million CNY | -5.86% |
| 2018 Q2 | 45.07 Million CNY | 5.75% |
| 2018 Q4 | 6.6 Million CNY | -84.43% |
| 2017 Q4 | 23.1 Million CNY | 31.69% |
| 2017 FY | 107.89 Million CNY | -41.06% |
| 2017 Q3 | 17.54 Million CNY | -43.49% |
| 2017 Q2 | 31.04 Million CNY | -14.21% |
| 2017 Q1 | 36.19 Million CNY | 2.55% |
| 2016 Q2 | 48.44 Million CNY | 65.46% |
| 2016 FY | 183.05 Million CNY | 18.63% |
| 2016 Q4 | 35.29 Million CNY | -49.6% |
| 2016 Q3 | 70.03 Million CNY | 44.55% |
| 2016 Q1 | 29.27 Million CNY | 6.82% |
| 2015 FY | 154.3 Million CNY | -2.1% |
| 2015 Q4 | 27.4 Million CNY | -45.82% |
| 2015 Q3 | 50.59 Million CNY | 89.79% |
| 2015 Q2 | 26.65 Million CNY | -46.31% |
| 2015 Q1 | 49.64 Million CNY | 99.86% |
| 2014 Q1 | 43.69 Million CNY | 0.0% |
| 2014 Q4 | 24.83 Million CNY | -63.39% |
| 2014 Q3 | 67.84 Million CNY | 219.62% |
| 2014 Q2 | 21.22 Million CNY | -51.42% |
| 2014 FY | 157.6 Million CNY | -6.76% |
| 2013 FY | 169.04 Million CNY | 19.14% |
| 2012 FY | 141.88 Million CNY | 7.19% |
| 2011 FY | 132.36 Million CNY | 42.4% |
| 2010 FY | 92.95 Million CNY | -14.79% |
| 2009 FY | 109.08 Million CNY | 0.0% |